Viewing Study NCT01815359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2026-02-24 @ 11:00 AM
Study NCT ID: NCT01815359
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-04
First Post: 2013-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Appendix Cancer View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ICARuS View
None Intraperitoneal Chemotherapy View
None hyperthermic intraperitoneal chemotherapy View
None Optimal Surgical Debulking View
None Leucovorin View
None Floxuridine (FUDR) View
None Mitomycin View
None 12-289 View